BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26974246)

  • 1. Molecular Genetic Profiling of Adolescent Glassy Cell Carcinoma of the Cervix Reveals Targetable EGFR Amplification with Potential Therapeutic Implications.
    McEachron TA; Sender LS; Zabokrtsky KB; Kaltenecker B; Holmes WN; Cherni I; Manojlovic Z; Liao SY; Craig DW; Carpten JD; Torno LR
    J Adolesc Young Adult Oncol; 2016 Sep; 5(3):297-302. PubMed ID: 26974246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of epidermal growth factor receptor expression and gene expression status in tissue microarray of cervical squamous cell carcinoma].
    Zhou SY; Feng GF; Chen GR; Pan D; Zhang PN; Yang XM; Xia ZL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):843-6. PubMed ID: 24444562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints.
    Blake EA; Ross MS; Ross ME; Matsuo K; Silverstein ET; Torno LR; Bhargava R; Post MD; Da Silva DM; Taylor S; Walia S; Roman L; McEachron TA
    Arch Gynecol Obstet; 2022 Feb; 305(2):439-447. PubMed ID: 34392396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.
    Bumrungthai S; Munjal K; Nandekar S; Cooper K; Ekalaksananan T; Pientong C; Evans MF
    J Transl Med; 2015 Jul; 13():244. PubMed ID: 26209091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.
    Narayanan R; Kim HN; Narayanan NK; Nargi D; Narayanan B
    Int J Oncol; 2012 Jan; 40(1):13-20. PubMed ID: 21946890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
    Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
    Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
    Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
    PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
    Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
    Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
    Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
    Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
    Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis.
    Guitarte C; Alagkiozidis I; Mize B; Stevens E; Salame G; Lee YC
    Gynecol Oncol; 2014 May; 133(2):186-91. PubMed ID: 24503463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
    Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
    Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
    Nasu K; Takai N; Narahara H
    J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
    von Knebel Doeberitz M; Gissmann L; zur Hausen H
    Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glassy cell carcinoma: a rare cervical neoplasm. Case report of two patients and review of the literature].
    Lépinoy A; Lescut N; Lassabe C; Bosset JF; Servagi-Vernat S
    Cancer Radiother; 2014 Jun; 18(3):211-4. PubMed ID: 24819246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression.
    Marzano R; Corrado G; Merola R; Sbiroli C; Guadagni F; Vizza E; Del Nonno F; Carosi M; Galati M M; Sperduti I; Cianciulli AM
    Eur J Cancer; 2004 Jul; 40(10):1624-9. PubMed ID: 15196550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
    Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
    Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.